GB Meka
Stocks to watch

XERS

Compare

XERIS BIOPHARMA HOLDINGS INC · Healthcare

$9.88
▼ 1.0%Close 2026-09-30

Live intraday price

Compare with our price levels

T212.44
T111.33
E18.41
E36.27
SL5.71

Close 2026-09-30: $9.88 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 14.9% · 1 whale recently bought

1 month
▲ 17.1%
3 months
▲ 23.5%
1 year
▲ 22.3%
Analyst target
$12.29 +24.3%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$8.41 -14.9%
E2$7.89 -20.1%
E3$6.27 -36.5%
Targets
T1$11.33 14.7%
T2$12.44 26.0%
T3$13.56 37.2%
Stop-loss
SL$5.71 -42.2%
Whale cost ~$6.27 -36.5%

Risk : reward 1 : 2.7Moves ~$0.56 a day

⚖️ Positives and risks

✓ Positives (5)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●แข็งแกร่งกว่าตลาด (S&P 500) +52% ใน 6 เดือน
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 12.29 (upside +24%, 7 ราย)
  • ●รายได้โต +29% เทียบปีก่อน
! Risks (2)
  • ●RSI 72 ซื้อมากเกินไป (Overbought) เสี่ยงย่อตัว
  • ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

McCulloch Kevin · Officer

2026-09-28 · 25,000 shares @ $10.00 · pre-planned sale (10b5-1)

$250,000

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$1.8B
Next earnings2026-11-05
P/E (price to earnings)-
Forward P/E (on expected earnings)25.0
Revenue growth (YoY)+28.7%
Earnings growth (YoY)-
Net profit margin-5.1%
ROE-
Debt to equity (D/E)-
Dividend yield-
Analyst targets (high / low)$18.00 / $8.00
Number of analysts7
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI72
MA50 / MA200$8.43 / $7.18
Distance from MA200+37.6%
MACDPositive
1-year high / low$11.33 / $5.25
vs. S&P 500 (6 months)+51.6%
Volume vs. average0.27×